| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S87913-1mg促销 |
≥98% | ￥900.00 ￥810.00 |
10 | - | - | - | - |
|
S87913-5mg促销 |
≥98% | ￥2700.00 ￥2430.00 |
10 | - | - | - | - |
|
S87913-10mg促销 |
≥98% | ￥4000.00 ￥3600.00 |
9 | - | - | - | - |
|
S87913-25mg促销 |
≥98% | ￥9500.00 ￥8550.00 |
6 | - | - | - | - |
|
S87913-50mg促销 |
≥98% | ￥11100.00 ￥9990.00 |
3 | - | - | - | - |
|
S87913-100mg促销 |
≥98% | ￥12000.00 ￥10800.00 |
2 | - | - | - | - |
|
| 产品描述： | HS-27, a fluorescently-tethered Hsp90 inhibitor, assays surface Hsp90 expression on intact tissue specimens. HS-27 is made up of the core elements of SNX-5422, an Hsp90 inhibitor, tethered via a PEG linker to a fluorescein derivative (fluorescein isothiocyanate or FITC), that binds to ectopically expressed Hsp90. HS-27 has potential use in a see-and-treat paradigm in breast cancer | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | HSP90;HSP | ||||||||||||||||||||
| 参考文献： | 1. Crouch BT, et al. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer. Sci Rep. 2019 Mar 5;9(1):3461. | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存条件： | 2-8℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京